When Medicare coverage for a drug, device, or other medical technology is conditioned on additional evidence development, several important policy questions arise: What will be the utility of the ...
A few weeks ago, I was invited to attend a webinar hosted by one of the world’s leading tech companies. The session was dedicated to purpose and employee engagement, topics that I believe are at the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results